We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$420M
AUM Growth
-$3.61M
Cap. Flow
-$34.9M
Cap. Flow %
-8.31%
Top 10 Hldgs %
45.2%
Holding
67
New
2
Increased
12
Reduced
44
Closed
4

Top Buys

Rank Stock Value
1
KEYS icon
Keysight
KEYS
+$3.37M
2
LHX icon
L3Harris
LHX
+$2.59M
3
TJX icon
TJX Companies
TJX
+$1.62M
4
GWW icon
W.W. Grainger
GWW
+$1.31M
5
SONY icon
Sony
SONY
+$1.25M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$6.59M
2
MSFT icon
Microsoft
MSFT
+$3.9M
3
OTIS icon
Otis Worldwide
OTIS
+$2.57M
4
SBUX icon
Starbucks
SBUX
+$2.55M
5
MDT icon
Medtronic
MDT
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 24.47%
2 Healthcare 21.67%
3 Industrials 18.1%
4 Consumer Staples 11.79%
5 Financials 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIN icon
26
Linde
LIN
$236B
$5.31M 1.26%
18,353
-2,789
-13% -$813K
CTVA icon
27
Corteva
CTVA
$60.5B
$5.3M 1.26%
119,555
+11,272
+10% +$521K
RTX icon
28
RTX Corp
RTX
$290B
$5.11M 1.21%
59,842
-78,362
-57% -$6.59M
PFE icon
29
Pfizer
PFE
$143B
$5.09M 1.21%
130,113
-16,640
-11% -$647K
KO icon
30
Coca-Cola
KO
$383B
$5.07M 1.21%
93,720
CPRT icon
31
Copart
CPRT
$28.5B
$5.07M 1.2%
153,676
-26,404
-15% -$819K
ULTA icon
32
Ulta Beauty
ULTA
$21.8B
$4.64M 1.1%
13,414
-1,513
-10% -$496K
BRK.B icon
33
Berkshire Hathaway Class B
BRK.B
$1.1T
$4.54M 1.08%
16,323
SONY icon
34
Sony
SONY
$137B
$4.17M 0.99%
214,440
+61,655
+40% +$1.25M
CME icon
35
CME Group
CME
$95.4B
$4.06M 0.97%
19,097
-2,080
-10% -$439K
NVS icon
36
Novartis
NVS
$302B
$3.97M 0.94%
43,519
-12,854
-23% -$1.14M
ALSN icon
37
Allison Transmission
ALSN
$9.51B
$3.88M 0.92%
97,521
-5,425
-5% -$231K
TRU icon
38
TransUnion
TRU
$16B
$3.58M 0.85%
32,568
-4,851
-13% -$506K
AXTA icon
39
Axalta
AXTA
$7.45B
$3.46M 0.82%
113,599
+28,359
+33% +$898K
GNTX icon
40
Gentex
GNTX
$5.1B
$3.11M 0.74%
94,038
-6,083
-6% -$211K
VVV icon
41
Valvoline
VVV
$5.06B
$3.07M 0.73%
94,544
+452
+0.5% +$14.1K
DOX icon
42
Amdocs
DOX
$6.03B
$3.01M 0.72%
38,964
-19,062
-33% -$1.47M
BDX icon
43
Becton Dickinson
BDX
$46.4B
$2.89M 0.69%
12,163
-104
-0.8% -$24.9K
WMT icon
44
Walmart Inc
WMT
$909B
$2.81M 0.67%
59,850
SNY icon
45
Sanofi
SNY
$107B
$2.54M 0.61%
48,326
+5,768
+14% +$301K
SWK icon
46
Stanley Black & Decker
SWK
$14.5B
$2.46M 0.59%
12,023
-1,752
-13% -$363K
RELX icon
47
RELX
RELX
$66.7B
$2.13M 0.51%
79,961
-4,049
-5% -$107K
CDW icon
48
CDW
CDW
$18.9B
$2.09M 0.5%
11,962
+5,962
+99% +$1.03M
MMM icon
49
3M
MMM
$91.8B
$1.87M 0.45%
11,281
-1,540
-12% -$257K
SBUX icon
50
Starbucks
SBUX
$119B
$1.86M 0.44%
16,670
-22,570
-58% -$2.55M

Similar funds

Foyston, Gordon, & Payne's Q2 2021 Portfolio in Review

As of Q2 2021, Foyston, Gordon, & Payne held 67 positions worth $420M, down 0.85% from $424M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $34.9M in Q2 2021, closing 4 positions and reducing 44 holdings. Its most notable exit was DuPont de Nemours, an estimated $2.33M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Foyston, Gordon, & Payne opened a new position in TJX Companies worth $1.6M.

  • Foyston, Gordon, & Payne's largest Q2 2021 buy was TJX Companies: 23,728 shares worth $1.6M.
  • Foyston, Gordon, & Payne added most to Keysight in Q2 2021, an estimated $3.37M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2021 reduction was RTX Corp, cutting an estimated $6.59M.
  • Foyston, Gordon, & Payne fully exited DuPont de Nemours in Q2 2021, selling an estimated $2.33M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 45% of its $420M portfolio in Q2 2021.
  • Foyston, Gordon, & Payne opened 2 new positions and closed 4 in Q2 2021.
  • Foyston, Gordon, & Payne's portfolio value fell 0.85% quarter-over-quarter to $420M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2021, filed 6 Aug 2021.